Scholars Central

Conference abstractPublished 24 Apr 2019

Novel natural product may be a new hope in the fi ght against liver cancer

Authors: Amr Amin

Professor in Molecular Biology, UAE University, UAE

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Th e multikinase inhibitor, sorafenib, remains for a decade now the fi rst and only systemic therapy for the treatment of hepatocellular carcinoma (HCC). Th us, a novel approach against HCC is essential for a better therapeutic outcome. Th e aim of this study is to assess the chemopreventive action of Saff ron’s main biomolecules against chemically-induced liver cancer in rats and to explore the mechanisms by which Saff ron’s biomolecules employ their anti-tumor eff ects. We provide a network analysis of diff erentially expressed genes in tissues of animals pre-treated with Saff ron’s biomolecules in comparison to induced-HCC animal's tissue. To further support our results, we assessed the in vitro eff ects of those natural products on cells viability and cell cycle distribution. Network analysis was also conducted and identifi ed NF-kB as a potential regulatory hub, and therefore, a candidate therapeutic drug target.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGastroenterology & Hepatology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Amr Amin”